14 January 2019

Discussing the news that the Scottish Medical Consortium (SMC) has approved pertuzumab (Perjeta) for use on NHS Scotland to treat secondary breast cancer1, Angela Harris, Head of Breast Cancer Care Scotland, says:

“With a huge sigh of relief, we welcome this fantastic decision. It’s absolutely wonderful that women across the UK diagnosed with incurable, secondary breast cancer can now access this innovative, life-extending treatment.   

“Women living with this cruel disease often tell us they feel robbed of their future. For them, nothing is more important than making as many precious memories as possible, and Perjeta can offer about an extra year of invaluable time.  

“However, shockingly we’ve heard from women who moved across the border, at an already incredibly difficult time, to access this treatment which could have been available sooner. In the future, the SMC and NICE must work together to ensure women living with secondary breast cancer get the best possible care, no matter where they live.”

-Ends-

Notes to editor

  1. For use in combination with trastuzumab and docetaxel in adult patients with HER2-positive metastatic or locally recurrent unresectable breast cancer, who have not received previous anti-HER2 therapy or chemotherapy for their metastatic disease.

For further information, please contact:

Georgia Tilley, Press Officer, Breast Cancer Care

020 3105 3360 (out of hours 07702 901 334)

About Breast Cancer Care

When you have breast cancer, everything changes. Time becomes measured in appointments. The next scan. The next results. The next challenge.

At Breast Cancer Care, we understand the emotions, challenges and decisions you face every day. So, from the day you notice something’s not right to the day you begin to move forward, we’ll be here to help you through.

Whether you want to speak to our nurses, download our specialist information or connect with volunteers who have faced what you are facing now, we can help you feel more in control.

For care, support and information from day one, call us free on 0808 800 6000 or visit breastcancercare.org.uk